Exciva, a biopharmaceutical company based in Heidelberg, has successfully closed a Series B funding round, raising €51 million ($59 million). The round was co-led by Gimv...
Recently, Covenant Health revealed that almost 500,000 individuals were affected by a data breach that occurred in May, as opposed to the initial report of 7,864...
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.